Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › T20/DP178 is an activator of human phagocyte formyl peptide receptors

T20/DP178 is an activator of human phagocyte formyl peptide receptors

US Patent 6830893 · Granted Dec 14, 2004

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody-mediated conditioning with immunosuppression to enable allogeneic trans2025
Interleukin-22 fusion proteins, and their pharmaceutical compositions2025
2K clearcoat composition, its preparation and use thereof2025
Human monoclonal antibody targeting TNFR2 for cancer immunotherapy2022
Reducing CXCR4 expression and/or function to enhance engraftment of hematopoieti2022
Therapeutic antitumor combination of a TLR4 ligand with other treatments2022
HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressant2017
HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressant2012
CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV in2012
Identification of biomarkers for liver toxicity2008
CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV in2008
CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV in2006